Management of hepatitis B: 2000—summary of a workshop
AS Lok, EJ Heathcote, JH Hoofnagle - Gastroenterology, 2001 - Elsevier
Chronic infection with the hepatitis B virus (HBV) is estimated to affect 400 million persons
and to be the single most common cause of cirrhosis and hepatocellular carcinoma (HCC) …
and to be the single most common cause of cirrhosis and hepatocellular carcinoma (HCC) …
Management of chronic hepatitis B
HS Conjeevaram, ASF Lok - Journal of Hepatology, 2003 - Elsevier
Hepatitis B virus (HBV) infection is a global public health problem [1]. It is the leading cause
of cirrhosis and hepatocellular carcinoma (HCC) worldwide. It is estimated there are at least …
of cirrhosis and hepatocellular carcinoma (HCC) worldwide. It is estimated there are at least …
[PDF][PDF] Chronic hepatitis B
ASF Lok, BJ McMahon - Hepatology, 2007 - Wiley Online Library
These guidelines have been written to assist physicians and other health care providers in
the recognition, diagnosis, and management of patients chronically infected with the …
the recognition, diagnosis, and management of patients chronically infected with the …
Chronic hepatitis B
ASF Lok, BJ McMahon - Hepatology, 2001 - journals.lww.com
These guidelines have been written to assist physicians and other health care providers in
the recognition, diagnosis, and management of patients chronically infected with the …
the recognition, diagnosis, and management of patients chronically infected with the …
A reappraisal of thymosin alpha1 in cancer therapy
Thymosin alpha1 (Tα1), an endogenous peptide first isolated from the thymic tissue in the
mid-sixties, has gained considerable attention for its immunostimulatory activity that led to its …
mid-sixties, has gained considerable attention for its immunostimulatory activity that led to its …
Hepatitis B virus: old, new and future approaches to antiviral treatment
P Karayiannis - Journal of Antimicrobial Chemotherapy, 2003 - academic.oup.com
Patients chronically infected with hepatitis B virus (HBV) run the risk of developing cirrhosis
and hepatocellular carcinoma in later life. Antiviral treatment offers the only means of …
and hepatocellular carcinoma in later life. Antiviral treatment offers the only means of …
The Thymosins
E Hannappel, T Huff - Vitamins & Hormones, 2003 - books.google.com
The Thymosins Page 278 7 The Thymosins Prothymosin, Parathymosin, and-Thymosins:
Structure and Function Ewald Hannappel and Thomas Huff Institute for Biochemistry/Faculty …
Structure and Function Ewald Hannappel and Thomas Huff Institute for Biochemistry/Faculty …
Management of viral hepatitis B
C Pramoolsinsup - Journal of gastroenterology and hepatology, 2002 - Wiley Online Library
Hepatitis B virus (HBV) infection is a major global health concern and is the most common
cause of chronic liver disease worldwide. The natural history and clinical outcomes of …
cause of chronic liver disease worldwide. The natural history and clinical outcomes of …
A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics
CP Desmond, A Bartholomeusz, S Gaudieri… - Antiviral …, 2008 - journals.sagepub.com
Background The immune response to hepatitis B virus (HBV) is important for both viral
control and disease pathogenesis. A detailed understanding of the HBV-specific T-cell …
control and disease pathogenesis. A detailed understanding of the HBV-specific T-cell …
Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial
P Andreone, S Fiorino, C Cursaro, A Gramenzi… - Antiviral research, 2001 - Elsevier
Background and aims: Interferon-α treatment has been the treatment of choice for chronic
hepatitis with unpredictable results. Recently, Lamivudine has been licensed for use against …
hepatitis with unpredictable results. Recently, Lamivudine has been licensed for use against …